Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 189

Similar articles for PubMed (Select 18463953)

1.

Overview of chemoradiation clinical trials for locally advanced non-small cell lung cancer in Japan.

Okamoto I.

Int J Clin Oncol. 2008 Apr;13(2):112-6. doi: 10.1007/s10147-007-0754-y. Epub 2008 May 8. Review.

PMID:
18463953
2.
3.
4.
5.
6.

Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.

Segawa Y, Kiura K, Takigawa N, Kamei H, Harita S, Hiraki S, Watanabe Y, Sugimoto K, Shibayama T, Yonei T, Ueoka H, Takemoto M, Kanazawa S, Takata I, Nogami N, Hotta K, Hiraki A, Tabata M, Matsuo K, Tanimoto M.

J Clin Oncol. 2010 Jul 10;28(20):3299-306. doi: 10.1200/JCO.2009.24.7577. Epub 2010 Jun 7.

7.

Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol.

Belani CP, Choy H, Bonomi P, Scott C, Travis P, Haluschak J, Curran WJ Jr.

J Clin Oncol. 2005 Sep 1;23(25):5883-91. Epub 2005 Aug 8. Erratum in: J Clin Oncol. 2006 Apr 20;24(12):1966.

8.

Radiation and third-generation chemotherapy.

Chen Y, Okunieff P.

Hematol Oncol Clin North Am. 2004 Feb;18(1):55-80. Review.

PMID:
15005281
9.

Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer.

Lee SW, Choi EK, Lee JS, Lee SD, Suh C, Kim SW, Kim WS, Ahn SD, Yi BY, Kim JH, Noh YJ, Kim SS, Koh Y, Kim DS, Kim WD.

Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):996-1004.

PMID:
12829135
10.

Scheduling of chemotherapy and radiotherapy in locally advanced non-small cell lung cancer.

Bishop JF.

Lung Cancer. 1995 Jun;12 Suppl 2:S53-61. Review.

PMID:
7551950
12.

Benefits and adverse events among elderly patients receiving concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: analysis of the Okayama Lung Cancer Study Group trial 0007.

Takigawa N, Kiura K, Segawa Y, Hotta K, Tamaoki A, Tokuda Y, Nagata T, Watanabe K, Gemba K, Moritaka T, Horita N, Takeda H, Okimoto N, Takemoto M, Matsuo K, Shinkai T, Tabata M, Ueoka H, Kanazawa S, Tanimoto M.

J Thorac Oncol. 2011 Jun;6(6):1087-91. doi: 10.1097/JTO.0b013e318213f86a.

PMID:
21415777
13.

Phase II study of twice-daily high-dose thoracic radiotherapy alternating with cisplatin and vindesine for unresectable stage III non-small-cell lung cancer: Japan Clinical Oncology Group Study 9306.

Sekine I, Nishiwaki Y, Ogino T, Yokoyama A, Saito M, Mori K, Tsukiyama I, Tsuchiya S, Hayakawa K, Yoshimura K, Ishizuka N, Saijo N.

J Clin Oncol. 2002 Feb 1;20(3):797-803.

PMID:
11821463
14.

A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.

Atagi S, Kawahara M, Hosoe S, Ogawara M, Kawaguchi T, Okishio K, Naka N, Sunami T, Mitsuoka S, Akira M.

Lung Cancer. 2002 Apr;36(1):105-11.

PMID:
11891041
15.
16.

A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study).

Choy H, Devore RF 3rd, Hande KR, Porter LL, Rosenblatt P, Yunus F, Schlabach L, Smith C, Shyr Y, Johnson DH.

Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):931-7.

PMID:
10863062
17.

[Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer].

Wang J, Pang QS, Wang P, Wang J, Wang W.

Zhonghua Zhong Liu Za Zhi. 2007 Oct;29(10):769-72. Chinese.

PMID:
18396691
18.

Combined chemotherapy and radiation in locally advanced non-small cell lung cancer.

Belani CP, Aisner J.

Semin Oncol. 1994 Jun;21(3 Suppl 6):79-90. Review.

PMID:
8052878
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk